Louise Baxter

Dr Louise Baxter

  • Lecturer in the Sociology of Health and Illness
Back to top

Journal Articles

  • Perkins, R., Mason-Bertrand, A., Fancourt, D., Baxter, L. and Williamon, A., 2020. How Participatory Music Engagement Supports Mental Well-being: A Meta-Ethnography. Qualitative Health Research, 30 (12), 1924-1940.
  • Aughterson, H., Baxter, L. and Fancourt, D., 2020. Social prescribing for individuals with mental health problems: A qualitative study of barriers and enablers experienced by general practitioners. BMC Family Practice, 21 (1).
  • Fancourt, D. and Baxter, L., 2020. Differential participation in community cultural activities amongst those with poor mental health: Analyses of the UK Taking Part Survey. Social Science and Medicine, 261.
  • Fancourt, D., Baxter, L. and Lorencatto, F., 2020. Barriers and enablers to engagement in participatory arts activities amongst individuals with depression and anxiety: Quantitative analyses using a behaviour change framework. BMC Public Health, 20 (1).
  • Baxter, L. and Fancourt, D., 2020. What are the barriers to, and enablers of, working with people with lived experience of mental illness amongst community and voluntary sector organisations? A qualitative study. PLoS One, 15 (7), e0235334.
  • Jauregui, B., Baxter, L. et al., 2015. Evidence-based decision-making for vaccine introductions: Overview of the ProVac International Working Group's experience. Vaccine, 33 (S1), A28-A33.
  • Javanbakht, M., Baxter, L. et al., 2015. Cost-effectiveness analysis of the introduction of rotavirus vaccine in Iran. Vaccine, 33 (S1), A192-A200.
  • Sibak, M., Baxter, L. et al., 2015. Cost-effectiveness analysis of the introduction of the pneumococcal conjugate vaccine (PCV-13) in the Egyptian national immunization program, 2013. Vaccine, 33 (S1), A182-A191.
  • Blau, J., Hoestlandt, C., Clark, A.D., Baxter, L., Felix Garcia, A.G., Mounaud, B. and Mosina, L., 2015. Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe. Vaccine, 33 (S1), A34-A39.
  • Hartwell, D., Cooper, K., Frampton, G.K., Baxter, L. and Loveman, E., 2014. The clinical effectiveness and cost-effectiveness of peginterferon alfa and ribavirin for the treatment of chronic hepatitis C in children and young people: A systematic review and economic evaluation. Health Technology Assessment, 18 (65).
  • Shepherd, J., Jones, J., Frampton, G.K., Bryant, J., Baxter, L. and Cooper, K., 2013. Clinical effectiveness and cost-effectiveness of depth of anaesthesia monitoring (E-Entropy, Bispectral Index and Narcotrend): A systematic review and economic evaluation. Health Technology Assessment, 17 (34), 1-264.
  • Hartwell, D., Jones, J., Baxter, L. and Shepherd, J., 2012. Shortened peginterferon and ribavirin treatment for chronic hepatitis C. International Journal of Technology Assessment in Health Care, 28 (4), 398-406.
  • Hartwell, D., Jones, J., Baxter, L. and Shepherd, J., 2011. Peginterferon alfa and ribavirin for chronic hepatitis c in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: A systematic review and economic evaluation. Health Technology Assessment, 15 (17), 1-208.
  • Takeda, A., Cooper, K., Bird, A., Baxter, L., Frampton, G.K., Gospodarevskaya, E., Welch, K. and Bryant, J., 2010. Recombinant human growth hormone for the treatment of growth disorders in children: A systematic review and economic evaluation. Health Technology Assessment, 14 (42), 1-237.
  • Jones, J., Shepherd, J., Baxter, L., Gospodarevskaya, E., Hartwell, D., Harris, P. and Price, A., 2009. Adefovir dipivoxil and pegylated interferon alpha for the treatment of chronic hepatitis B: An updated systematic review and economic evaluation. Health Technology Assessment, 13 (35).
  • Bryant, J., Baxter, L. and Hird, S., 2009. Non-occupational postexposure prophylaxis for HIV: A systematic review. Health Technology Assessment, 13 (14).
  • Picot, J., Jones, J., Colquitt, J.L., Gospodarevskaya, E., Loveman, E., Baxter, L. and Clegg, A.J., 2009. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: A systematic review and economic evaluation. Health Technology Assessment, 13 (41).
  • Bryant, J., Picot, J., Baxter, L., Levitt, G., Sullivan, I. and Clegg, A., 2007. Use of cardiac markers to assess the toxic effects of anthracyclines given to children with cancer: A systematic review. European Journal of Cancer, 43 (13), 1959-1966.
  • Bryant, J., Picot, J., Levitt, G., Sullivan, I., Baxter, L. and Clegg, A., 2007. Cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review. HEALTH TECHNOLOGY ASSESSMENT, 11 (27), 1-+.
  • Bryant, J., Picot, J., Baxter, L., Levitt, G., Sullivan, I. and Clegg, A., 2007. Clinical and cost-effectiveness of cardioprotection against the toxic effects of anthracyclines given to children with cancer: A systematic review. British Journal of Cancer, 96 (2), 226-230.
  • Bryant, J., Picot, J., Levitt, G., Sullivan, I., Baxter, L. and Clegg, A., 2007. Cardioprotection against the toxic effects of anthracyclines given to children with cancer: A systematic review. Health Technology Assessment, 11 (27).
  • Baxter, L., Bryant, J., Cave, C.B. and Milne, R., 2007. Recombinant growth hormone for children and adolescents with Turner syndrome. Cochrane Database of Systematic Reviews.
  • Bryant, J., Baxter, L., Cave, C.B. and Milne, R., 2007. Recombinant growth hormone for idiopathic short stature in children and adolescents. Cochrane Database of Systematic Reviews.

Profile of Teaching UG

  • Crime, Health and Society
  • Quantitative Research Skills
  • The Sociology of Health and Illness
  • Introduction to Social Research

Grants

  • Developing guidelines for involving people experiencing mental ill-health in heritage projects (MARCH mental health research network, 02 Nov 2020). Awarded